A surface-eroding antibiotic delivery system based on poly-(trimethylene carbonate).

Biodegradable delivery systems that do not produce acidic compounds during degradation are preferred for local antibiotic delivery in bone infections in order to avoid adverse bone reactions. Poly(trimethylene carbonate) (PTMC) has good biocompatibility, and is such a polymer. The objective of this in vitro study was to explore the suitability of PTMC as an antibiotic releasing polymer for the local treatment of bone infections. Degradation behaviour and corresponding release profiles of gentamicin and vancomycin from slowly degrading PTMC168 and faster degrading PTMC339 discs were compared in the absence and presence of a lipase solution. Gentamicin release in the absence of lipase was diffusion-controlled, while vancomycin release was limited. Surface erosion of PTMC only occurred in the presence of lipase. Both antibiotics were released in high concentrations from PTMC in the presence of lipase through a combination of surface erosion and diffusion. This illustrates the major advantage of surface-eroding biodegradable polymers, allowing release of larger antibiotic molecules like vancomycin.

[1]  A. U. Daniels,et al.  Six bioabsorbable polymers: in vitro acute toxicity of accumulated degradation products. , 1994, Journal of applied biomaterials : an official journal of the Society for Biomaterials.

[2]  J. Dawson,et al.  The use of vancomycin and tobramycin in acrylic bone cement: biomechanical effects and elution kinetics for use in joint arthroplasty. , 1999, The Journal of arthroplasty.

[3]  N. Peppas,et al.  Present and future applications of biomaterials in controlled drug delivery systems. , 1981, Biomaterials.

[4]  Anthony W Smith,et al.  Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? , 2005, Advanced drug delivery reviews.

[5]  E. Dingeldein,et al.  Antibiotics and bone cements. Experimental and clinical long-term observations. , 1980, Acta orthopaedica Scandinavica.

[6]  J. Mader,et al.  Methicillin-resistant Staphylococcus aureus osteomyelitis. , 1985, Clinical orthopaedics and related research.

[7]  G. Gosheger,et al.  Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis. , 2005, Biomaterials.

[8]  A. Boulton,et al.  Methicillin‐resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[9]  J. Pedraz,et al.  In vivo evaluation of EPO-secreting cells immobilized in different alginate-PLL microcapsules. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Jan Feijen,et al.  The in vivo and in vitro degradation behavior of poly(trimethylene carbonate). , 2006, Biomaterials.

[11]  A. Gristina,et al.  Adherent bacterial colonization in the pathogenesis of osteomyelitis , 2007 .

[12]  J. Feijen,et al.  Triblock Copolymers Based on 1,3‐Trimethylene Carbonate and Lactide as Biodegradable Thermoplastic Elastomers , 2003 .

[13]  Shih-Jung Liu,et al.  In vivo release of vancomycin from biodegradable beads. , 2002, Journal of biomedical materials research.

[14]  J. Siepmann,et al.  Mathematical modeling of bioerodible, polymeric drug delivery systems. , 2001, Advanced drug delivery reviews.

[15]  Robert Langer,et al.  Advances in Biomaterials, Drug Delivery, and Bionanotechnology , 2003 .

[16]  A. Göpferich,et al.  Why degradable polymers undergo surface erosion or bulk erosion. , 2002, Biomaterials.

[17]  J. Costerton,et al.  Antibiotic resistance of bacteria in biofilms , 2001, The Lancet.

[18]  R. Zhuo,et al.  Synthesis and drug release behavior of poly (trimethylene carbonate)-poly (ethylene glycol)-poly (trimethylene carbonate) nanoparticles. , 2005, Biomaterials.

[19]  P. Stewart,et al.  Biofilms in chronic wounds , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[20]  A A Poot,et al.  In vivo behavior of poly(1,3-trimethylene carbonate) and copolymers of 1,3-trimethylene carbonate with D,L-lactide or epsilon-caprolactone: Degradation and tissue response. , 2003, Journal of biomedical materials research. Part A.

[21]  A. Albertsson,et al.  Influence of molecular structure on the degradation mechanism of degradable polymers: In vitro degradation of poly(trimethylene carbonate), poly(trimethylene carbonate-co-caprolactone), and poly(adipic anhydride) , 1995 .